Riding The GLP-1 Boom, VITL Lands $7.5M To Overhaul Cash-Pay Clinic Prescribing
VITL lands $7.5M Series A to transform cash-pay clinic e-prescribing — cutting prescription time from minutes to seconds amid the GLP-1 boom.
Matilda
Riding The GLP-1 Boom, VITL Lands $7.5M To Overhaul Cash-Pay Clinic Prescribing
VITL Raises $7.5M to Fix Cash-Pay Clinic Prescribing Forever Nashville startup VITL is reshaping how weight-loss clinics, med-spas, and concierge practices handle prescriptions — cutting the process from several minutes down to just seconds. With $7.5 million in fresh Series A funding, the 18-month-old company is accelerating its mission to modernize cash-pay healthcare, a sector booming on the back of GLP-1 demand and growing patient appetite for out-of-pocket medical care. The Cash-Pay Healthcare Boom Has a Hidden Tech Problem The rise of GLP-1 drugs like Ozempic and Wegovy has turbocharged an entire ecosystem of weight-loss clinics, med-spas, and membership-based concierge practices. Patients are flocking to these providers for faster, more personalized care — and they are willing to pay for it out of pocket. But behind the scenes, these same clinics are running on outdated infrastructure. Many still rely on faxes and phone calls to send prescriptions to compounding pharmacies, creati…
